Tandem Diabetes Care
TNDM
TNDM
321 hedge funds and large institutions have $6.16B invested in Tandem Diabetes Care in 2020 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 111 increasing their positions, 115 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 115
2.44% less ownership
Funds ownership: 92.12% → 89.68% (-2.4%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
321
Holding in Top 10
8
Calls
$175M
Puts
$92.9M
Top Buyers
| 1 | +$83.6M | |
| 2 | +$64.9M | |
| 3 | +$55.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$29.1M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$28.5M |
Top Sellers
| 1 | -$296M | |
| 2 | -$44.5M | |
| 3 | -$29.2M | |
| 4 |
Morgan Stanley
New York
|
-$24.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$16.7M |